Skip to main content
Neil McDonnell

Neil McDonnell

Seal Rock Therapeutics
30 years in drug development and executive leadership in small- and mid-size biotechs, global pharmaceutical companies and global health institutions. CEO and co-founder of Seal Rock Therapeutics, first CEO of Metacrine, Senior Vice President and Therapeutic Area Leader for Cardiovascular and Metabolic Diseases at Takeda Pharmaceuticals, Chief of Staff for the Global Health Program at the Bill & Melinda Gates Foundation, VP Program Management at Zymogenetics, Head of Specialty Therapeutics franchise at Immunex